Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
2012 مئی کو شامل ہوئے
5 Photos and videos تصاویر اور ویڈیوز

ٹویٹس

آپ نے @AblynxABLX کو بلاک کردیا

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @AblynxABLX

  1. Retweeted
    26 جولائی

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 ریٹویٹس 4 likes
  2. Retweeted
    20 جولائی

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 ریٹویٹس 7 likes
  3. 20 جولائی

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 جواب 9 ریٹویٹس 14 likes
  4. 27 جون

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 ریٹویٹس 16 likes
  5. 26 جون

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 ریٹویٹس 6 likes
  6. 29 مئی

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 ریٹویٹس 9 likes
  7. 22 مئی

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 ریٹویٹس 12 likes
  8. 18 مئی

    Meet our experts and recruiters (booth 99) @

    2 likes
  9. 11 مئی

    Ablynx zit op schema via

    4 ریٹویٹس 6 likes
  10. 11 مئی

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 ریٹویٹس 4 likes
  11. 10 مئی

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 ریٹویٹس 7 likes
  12. 2 مئی

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 ریٹویٹس 6 likes
  13. 7 اپریل

    Annual Report 2016 is available online - view via

    1 ریٹویٹ 4 likes
  14. 7 اپریل

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 ریٹویٹ 4 likes
  15. Retweeted
    6 مارچ

    Compelling data for developed psoriasis nanobody in collaboration

    3 ریٹویٹس 2 likes
  16. Retweeted
    28 فروری

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 جوابات 51 ریٹویٹس 103 likes
  17. Retweeted
    24 فروری

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 ریٹویٹ 1 like
  18. 23 فروری

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 ریٹویٹس 3 likes
  19. 9 فروری

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 ریٹویٹس 2 likes
  20. 6 فروری

    Ablynx files caplacizumab for ultra rare blood disorder
    6 ریٹویٹس 9 likes

@AblynxABLX hasn't Tweeted yet.

لوڈنگ میں وقت لگ رہا ہے.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    آپ کو بھی پسند ہو

    ·